This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.62% per year. These returns cover a period from January 1, 1988 through June 2, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
5 ETFs That Beat the Market in the First Half of 2025
by Sweta Killa
SGDM, SLVP, SHLD, URA and PSIL top the charts in the first half of 2025, defying market turmoil and riding sector-specific surges.
The Zacks Analyst Blog Highlights SGDM, SLVP, SHLD, COPJ and PSIL
by Zacks Equity Research
SGDM, SLVP, SHLD, COPJ and PSIL are part of the Zacks top Analyst Blog.
5 Sector ETFs That Have Outperformed the S&P 500 in Q1
by Sweta Killa
Here are a few ETFs that have outperformed the S&P 500 in the first quarter.
5 Best-Performing Sector ETFs Halfway Through Q1
by Sweta Killa
At mid-way through the first quarter, Wall Street has been on a bull run, outplaying tariff trade war fears.
5 Best-Performing Sector ETFs of Volatile January
by Sweta Killa
January was full of events and surprises for Wall Street. Here are the five top-performing ETFs that were the leaders in January.
5 Best-Performing ETFs of January
by Sanghamitra Saha
Wall Street has been upbeat in January, with the Dow Jones outperforming the S&P 500 and the Nasdaq.
5 Best-Performing Sector ETFs of Q4
by Sweta Killa
We have highlighted five top-performing ETFs from different sectors that were the leaders in the fourth quarter.
The Zacks Analyst Blog Highlights AdvisorShares Psychedelics ETF, Simplify Volt Robocar Disruption and Tech ETF, First Trust SkyBridge Crypto Industry & Digital Economy ETF, U.S. Global Jets ETF and First Trust NASDAQ ABA Community Bank Index Fund
by Zacks Equity Research
AdvisorShares Psychedelics ETF, Simplify Volt Robocar Disruption and Tech ETF, First Trust SkyBridge Crypto Industry & Digital Economy ETF, U.S. Global Jets ETF and First Trust NASDAQ ABA Community Bank Index Fund are included in this Analyst Blog.
5 Best-Performing Sector ETFs Midway in Q4
by Sweta Killa
After reaching a record high, all three bourses lost momentum on sticky inflation and the Fed's hawkish comments.
5 Best-Performing ETFs of October
by Sanghamitra Saha
Wall Street delivered a muted performance in October. But these ETFs returned more than 10%.
Top and Flop ETFs of the First Nine Months
by Sweta Killa
We have highlighted three ETFs each from the best and worst-performing zones in the first nine months of 2024.
Time for Healthcare ETFs?
by Sanghamitra Saha
Compelling valuation, innovation in specific growth areas and an aging population as well as increasing healthcare spending are the tailwinds of the medical sector.
Top and Flop ETFs of the First Half
by Sweta Killa
We have highlighted three ETFs each from the best and worst-performing zones in the first half of 2024.
Best and Worst ETF Zones of Q2
by Sweta Killa
Technology remained the best-performing sector of the second quarter on the AI drive while energy lagged.
Top & Flop ETFs of August
by Sanghamitra Saha
August was an average-to-downbeat month for investors, mainly due to rising rates.
Best-Performing ETFs of August Up At Least 15%
by Sanghamitra Saha
These ETFs gained at least 15% in the downbeat month of August.
The Zacks Analyst Blog Highlights PSIL, MLPO, MJUS, URNM and IEO
by Zacks Equity Research
PSIL, MLPO, MJUS, URNM and IEO are part of The Zacks top Analyst Blog.
5 Top-Performing Sector ETFs of August
by Sweta Killa
The month of August was marked by ups and downs.
Diversify Your Portfolio With a New Psychedelic Drug ETF
by Sweta Jaiswal, FRM
A new thematic ETF providing exposure to the medicinal psychedelic drug industry, PSYK ETF, has just been launched.
The Zacks Analyst Blog Highlights: PSY, PSIL, Atai Life Sciences, COMPASS Pathways and Field Trip Health
by Zacks Equity Research
The Zacks Analyst Blog Highlights: PSY, PSIL, Atai Life Sciences, COMPASS Pathways and Field Trip Health.
3 Psychedelic Stocks to Play the Shroom Boom
by Sejuti Banerjea
Psychedelic substances are often grouped together with cannabis, but there are some important distinctions. ATAI, CMPS and FTRP are some of the best stocks in the space.